WA
GSK icon

Winfield Associates’s GSK GSK Stock Holding History

Winfield Associates’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-336
Closed -$15K – 330
2017
Q4 		$15K Sell
336
-252
-43% -$11.6K 0.01% 361
2017
Q3 		$30K Buy
588
+24
+4% +$1.22K 0.02% 239
2017
Q2 		$30K Buy
564
+32
+6% +$1.71K 0.02% 232
2017
Q1 		$28K Sell
532
-84
-14% -$4.26K 0.02% 229
2016
Q4 		$30K Buy
616
+116
+23% +$5.73K 0.02% 220
2016
Q3 		$27K Hold
500
– – 0.02% 223
2016
Q2 		$27K Buy
500
+12
+2% +$632 0.02% 225
2016
Q1 		$25K Buy
+488
New +$24.3K 0.02% 219

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Winfield Associates's GSK Position: Q1 2018 in Review

Winfield Associates sold out of GSK (GSK) in Q1 2018, closing a stake of 336 shares — an estimated $15K sold.

Winfield Associates first reported a position in GSK in Q1 2016 and held it in 8 quarters. The position peaked at $30K in Q3 2017. 778 funds tracked by Wall St. Rank hold GSK as of Q1 2018.

  • Winfield Associates reported no remaining GSK position as of Q1 2018 after selling out during the quarter.
  • Winfield Associates sold 336 GSK shares in Q1 2018, an estimated $15K.
  • Winfield Associates first reported a position in GSK in Q1 2016 and held it in 8 quarters.
  • Winfield Associates's GSK position peaked at $30K in Q3 2017.
  • 778 funds tracked by Wall St. Rank held GSK as of Q1 2018.

Based on Winfield Associates's 13F filing for Q1 2018, filed 10 May 2018.